October 2016 – During the last twenty years CROss Alliance group has evolved experiencing innovative changesto adapt to the mutating clinical research landscape, but always working under the same brand name and maintaining its identity.
In the year of our 20th anniversary, we are pleased to inform our customers that the European Union Intellectual Property Office (EUIPO) has renovated the Certificate of Registration, which officially confirms our logo as an European trademark.
This certification consolidates our brand identity and increases our visibility and market exposure.
In a changing and sometimes evanescent World, CROss Alliance group confirms once more its stable and reliable presence in the clinical trials arena.